Evidence map›Paper›PMID 30689758›Full record

ArticleBrain : a journal of neurology2019

The role of astrocytes in seizure generation: insights from a novel in vitro seizure model based on mitochondrial dysfunction.

Felix Chan, Nichola Z Lax, Caroline Marie Voss, Blanca Irene Aldana, Shuna Whyte, Alistair Jenkins, Claire Nicholson, Sophie Nichols, Elizabeth Tilley, Zoe Powell and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.9field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Mitochondria-related HSDL2 is a potential biomarker in temporal lobe epilepsy by modulating astrocytic lipid metabolism.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  13. Review
  14. Review
  15. Observational
  16. Article
  17. Article
  18. Review
  19. Article
  20. Role ofFrontiers in molecular neuroscience · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 3 countries.

Felix ChanInstitute of Neuroscience, Newcastle University, The Medical School, Framlington Place, Newcastle upon Tyne, UK.
Nichola Z LaxWellcome Centre for Mitochondrial Research, Newcastle University, Institute of Neuroscience, The Medical School, Framlington Place, Newcastle upon Tyne, UK.
Caroline Marie VossDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Blanca Irene AldanaDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Shuna WhyteInstitute of Neuroscience, Newcastle University, The Medical School, Framlington Place, Newcastle upon Tyne, UK.
Alistair JenkinsDepartment of Neurosurgery, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Claire NicholsonDepartment of Neurosurgery, Royal Victoria Infirmary, Newcastle upon Tyne, UK.
Sophie NicholsInstitute of Neuroscience, Newcastle University, The Medical School, Framlington Place, Newcastle upon Tyne, UK.
Elizabeth TilleyInstitute of Neuroscience, Newcastle University, The Medical School, Framlington Place, Newcastle upon Tyne, UK.
Zoe PowellInstitute of Neuroscience, Newcastle University, The Medical School, Framlington Place, Newcastle upon Tyne, UK.
Helle S WaagepetersenDepartment of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
Ceri H DaviesNeural Pathways DPU, GSK, 11 Biopolis Way, Singapore.
Doug M TurnbullWellcome Centre for Mitochondrial Research, Newcastle University, Institute of Neuroscience, The Medical School, Framlington Place, Newcastle upon Tyne, UK.
Mark O CunninghamInstitute of Neuroscience, Newcastle University, The Medical School, Framlington Place, Newcastle upon Tyne, UK.
Newcastle University · GBUniversity of Copenhagen · DKRoyal Victoria Infirmary · GBWellcome Centre for Mitochondrial Research · GB

Funding

Medical Research Council G0800674Medical Research Council G1100540Medical Research Council MR/K000608/1Medical Research Council MR/L016354/1Wellcome TrustWellcome Trust 203105/Z/16/Z
6 · The paper itself

Abstract

Approximately one-quarter of patients with mitochondrial disease experience epilepsy. Their epilepsy is often severe and resistant towards conventional antiepileptic drugs. Despite the severity of this epilepsy, there are currently no animal models available to provide a mechanistic understanding of mitochondrial epilepsy. We conducted neuropathological studies on patients with mitochondrial epilepsy and found the involvement of the astrocytic compartment. As a proof of concept, we developed a novel brain slice model of mitochondrial epilepsy by the application of an astrocytic-specific aconitase inhibitor, fluorocitrate, concomitant with mitochondrial respiratory inhibitors, rotenone and potassium cyanide. The model was robust and exhibited both face and predictive validity. We then used the model to assess the role that astrocytes play in seizure generation and demonstrated the involvement of the GABA-glutamate-glutamine cycle. Notably, glutamine appears to be an important intermediary molecule between the neuronal and astrocytic compartment in the regulation of GABAergic inhibitory tone. Finally, we found that a deficiency in glutamine synthetase is an important pathogenic process for seizure generation in both the brain slice model and the human neuropathological study. Our study describes the first model for mitochondrial epilepsy and provides a mechanistic insight into how astrocytes drive seizure generation in mitochondrial epilepsy.

Indexed as

AdultAgedAnimalsAstrocytesEpilepsy, Temporal LobeFemaleHumansMaleMiceMice, Inbred C57BLMiddle AgedMitochondriaMitochondrial DiseasesOrgan Culture TechniquesRatsRats, Wistar

Identifiers

PMID30689758
PMCPMC6519661
OpenAlexW2911824951

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.